WaveMan · Form 4
Novo Holdings A/S insider trades
> Search tickers & screens ⌘K
LIVE

Novo Holdings A/S insider trades

Novo Holdings A/S has filed 28 Form 4s with the SEC that we hold, for CYT (10% owner), IO Biotech, Inc. (IOBT) (10% owner), Spruce Biosciences, INC. (SPRB) (10% owner) and ACLX (10% owner), among 14 companies in all. Across all of them we count 10 purchases worth $80.2M and 33 sales worth $69.0M reported on Form 4. In the last 12 months: 2 purchases ($26.2M) and 0 sales ($0). The largest single trade was a sale of 1,250,000 shares of Disc Medicine, Inc. worth $57.6M, dated 2023-06-28. The first filing on our record is dated 2021-10-27 and the latest 2026-05-06.

CYT

10% owner · 8 filings · 18 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-07-20S, sale reported on Form 4900,000$2.7M2022-07-22
2023-06-12S, sale reported on Form 4900$1.9K2023-06-14
2023-06-13S, sale reported on Form 42,626$5.5K2023-06-14
2023-06-14S, sale reported on Form 42,872$6.1K2023-06-14
2023-06-15S, sale reported on Form 410,002$20.3K2023-06-20
2023-06-16S, sale reported on Form 45,983$12.1K2023-06-20
2023-06-20S, sale reported on Form 4744$1.6K2023-06-20
2023-06-21S, sale reported on Form 44,834$9.6K2023-06-23
2023-06-22S, sale reported on Form 45,041$9.8K2023-06-23
2023-06-23S, sale reported on Form 43,423$6.4K2023-06-23
2023-06-26S, sale reported on Form 48,437$15.1K2023-06-28
2023-06-27S, sale reported on Form 431,978$56.6K2023-06-28
2023-06-30S, sale reported on Form 4200,937$528.5K2023-07-03
2023-07-14S, sale reported on Form 411,000$30.1K2023-07-18
2023-07-17S, sale reported on Form 421,100$58.0K2023-07-18
2023-07-18S, sale reported on Form 46,500$17.9K2023-07-18
2023-07-19S, sale reported on Form 41,900$5.2K2023-07-20
2023-07-20S, sale reported on Form 4100,000$275.0K2023-07-20

IO Biotech, Inc. (IOBT)

10% owner · 5 filings · 6 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-11-09P, purchase reported on Form 4325,000$4.5M2021-11-10
2023-08-09P, purchase reported on Form 42,469,135$5.0M2023-08-11
2024-02-09S, sale reported on Form 4658,809$988.2K2024-02-13
2024-05-10S, sale reported on Form 4658,809$803.7K2024-05-14
2024-07-25S, sale reported on Form 451,522$68.5K2024-07-26
2024-07-26S, sale reported on Form 423,478$30.8K2024-07-26

Spruce Biosciences, INC. (SPRB)

10% owner · 4 filings · 6 purchases and sales
Trade dateCodeSharesValue as filedFiled
2023-02-16P, purchase reported on Form 42,208,000$7.0M2023-02-21
2024-03-14S, sale reported on Form 41,912,316$1.7M2024-03-18
2024-03-18S, sale reported on Form 4842,020$648.4K2024-03-20
2024-03-19S, sale reported on Form 4593,000$450.7K2024-03-20
2024-03-20S, sale reported on Form 4359,979$262.8K2024-03-20
2024-03-21S, sale reported on Form 4465,021$348.8K2024-03-25

ACLX

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2022-02-08P, purchase reported on Form 4833,333$12.5M2022-02-09

Avalyn Pharma Inc. (AVLN)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2026-05-01P, purchase reported on Form 4555,555$10.0M2026-05-05

Bolt Biotherapeutics, Inc. (BOLT)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2022-07-13S, sale reported on Form 4800,000$1.6M2022-07-15

CMPI

10% owner · 1 filing · 3 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-02-23S, sale reported on Form 41,820$5.3K2022-02-25
2022-02-24S, sale reported on Form 45,990$17.0K2022-02-25
2022-02-25S, sale reported on Form 4300$8102022-02-25

Disc Medicine, Inc. (IRON)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-06-28S, sale reported on Form 41,250,000$57.6M2023-06-28

Edgewise Therapeutics, Inc. (EWTX)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2022-09-14P, purchase reported on Form 4484,496$5.0M2022-09-16

Hemab Therapeutics Holdings, Inc. (COAG)

10% owner · 1 filing · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

MapLight Therapeutics, Inc. (MPLT)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2025-10-28P, purchase reported on Form 4952,941$16.2M2025-10-30

Metagenomi Therapeutics, Inc. (MGX)

10% owner · 1 filing · 2 purchases and sales
Trade dateCodeSharesValue as filedFiled
2024-02-09P, purchase reported on Form 4100,000$1.0M2024-02-15
2024-02-13P, purchase reported on Form 4800,000$12.0M2024-02-15

OnKure Therapeutics, Inc. (RPHM)

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2023-06-23S, sale reported on Form 4100,000$710.0K2023-06-23

UTRS

10% owner · 1 filing · 1 purchase or sale
Trade dateCodeSharesValue as filedFiled
2021-10-26P, purchase reported on Form 4580,000$7.0M2021-10-27
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1388325) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms